Felix Registration Achieved in Vietnam and Cartridge Order
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Memphasys Ltd has announced the successful registration of its Felix™ System in Vietnam, allowing for full commercial sales to begin. The company has reported the first successful pregnancy following the use of the Felix™ System in Vietnam, indicating positive early engagement with fertility clinics. Memphasys is now focused on converting initial clinic engagement into ongoing sales as part of its commercial rollout strategy.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Memphasys
- Pivotal Felix Study Receives First Scientific Presentation
- European Commercial Roll-out continues with Poland Agreement
- Exclusive Thailand Commercialisation Agreement Secured
- UK Market Entry & Acceleration of Commercial Expansion
- Successful $1.2M Placement and Convertible Note Extended
Later from Memphasys
- Results of General Meeting
- Felix Early Thai FDA Approval, Commercial Launch Accelerates
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
- EUR526,500 Nordic Agreement Expands Felix European Footprint
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys